{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T09:17:54Z","timestamp":1712222274649},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1007\/s00115-013-3845-1","type":"journal-article","created":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:58:08Z","timestamp":1380589088000},"page":"1247-1259","source":"Crossref","is-referenced-by-count":2,"title":["Klinisch isoliertes Syndrom"],"prefix":"10.1007","volume":"84","author":[{"given":"M.","family":"Platten","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Lanz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Bendszus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Diem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,10,2]]},"reference":[{"key":"3845_CR1","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1136\/jnnp.2007.134825","volume":"79","author":"Henry","year":"2008","unstructured":"Henry RG, Shieh M, Okuda DT et al (2008) Regional grey matter atrophy in clinically isolated syndromes at presentation. J Neurol Neurosurg Psychiatry 79:1236\u20131244","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3845_CR2","doi-asserted-by":"crossref","first-page":"e51645","DOI":"10.1371\/journal.pone.0051645","volume":"7","author":"Suhs","year":"2012","unstructured":"Suhs KW, Hein K, Pehlke JR et al (2012) Retinal nerve fibre layer thinning in patients with clinically isolated optic neuritis and early treatment with interferon-beta. PLoS One 7:e51645","journal-title":"PLoS One"},{"key":"3845_CR3","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1056\/NEJM199801293380502","volume":"338","author":"Trapp","year":"1998","unstructured":"Trapp BD, Peterson J, Ransohoff RM et al (1998) Axonal transection in the lesions of multiple sclerosis. New Engl J Med 338:278\u2013285","journal-title":"New Engl J Med"},{"key":"3845_CR4","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/brain\/awl007","volume":"129","author":"Confavreux","year":"2006","unstructured":"Confavreux C, Vukusic S (2006) Natural history of multiple sclerosis: a unifying concept. Brain 129:606\u2013616","journal-title":"Brain"},{"key":"3845_CR5","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1093\/brain\/awq118","volume":"133","author":"Scalfari","year":"2010","unstructured":"Scalfari A, Neuhaus A, Degenhardt A et al (2010) The natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disability. Brain 133:1914\u20131929","journal-title":"Brain"},{"key":"3845_CR6","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","volume":"69","author":"Polman","year":"2011","unstructured":"Polman CH, Reingold SC, Banwell B et al (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69:292\u2013302","journal-title":"Ann Neurol"},{"key":"3845_CR7","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(11)70274-5","volume":"11","author":"Miller","year":"2012","unstructured":"Miller DH, Chard DT, Ciccarelli O (2012) Clinically isolated syndromes. Lancet Neurol 11:157\u2013169","journal-title":"Lancet Neurol"},{"key":"3845_CR8","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1212\/WNL.0b013e31827b1a67","volume":"80","author":"Sombekke","year":"2013","unstructured":"Sombekke MH, Wattjes MP, Balk LJ et al (2013) Spinal cord lesions in patients with clinically isolated syndrome: a powerful tool in diagnosis and prognosis. Neurology 80:69\u201375","journal-title":"Neurology"},{"key":"3845_CR9","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1136\/jnnp-2012-304695","volume":"84","author":"Dobson","year":"2013","unstructured":"Dobson R, Ramagopalan S, Davis A et al (2013) Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude. J Neurol Neurosurg Psychiatry 84:909\u2013914","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3845_CR10","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1212\/01.wnl.0000280576.73609.c6","volume":"70","author":"Tintore","year":"2008","unstructured":"Tintore M, Rovira A, Rio J et al (2008) Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis? Neurology 70:1079\u20131083","journal-title":"Neurology"},{"key":"3845_CR11","doi-asserted-by":"crossref","first-page":"e40431","DOI":"10.1371\/journal.pone.0040431","volume":"7","author":"Brecht","year":"2012","unstructured":"Brecht I, Weissbrich B, Braun J et al (2012) Intrathecal, polyspecific antiviral immune response in oligoclonal band negative multiple sclerosis. PLoS One 7:e40431","journal-title":"PLoS One"},{"key":"3845_CR12","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1177\/1352458506071196","volume":"13","author":"Feuillet","year":"2007","unstructured":"Feuillet L, Reuter F, Audoin B et al (2007) Early cognitive impairment in patients with clinically isolated syndrome suggestive of multiple sclerosis. Mult Scler 13:124\u2013127","journal-title":"Mult Scler"},{"key":"3845_CR13","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1177\/1352458511431076","volume":"18","author":"Langdon","year":"2012","unstructured":"Langdon DW, Amato MP, Boringa J et al (2012) Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS). Mult Scler 18:891\u2013898","journal-title":"Mult Scler"},{"key":"3845_CR14","doi-asserted-by":"crossref","unstructured":"Oberwahrenbrock T, Ringelstein M, Jentschke S et al (2013) Retinal ganglion cell and inner plexiform layer thinning in clinically isolated syndrome. Mult Scler [Epub ahead of print]","DOI":"10.1177\/1352458513489757"},{"key":"3845_CR15","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1177\/1352458508096878","volume":"14","author":"Miller","year":"2008","unstructured":"Miller DH, Weinshenker BG, Filippi M et al (2008) Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler 14:1157\u20131174","journal-title":"Mult Scler"},{"key":"3845_CR16","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","volume":"6","author":"Wingerchuk","year":"2007","unstructured":"Wingerchuk DM, Lennon VA, Lucchinetti CF et al (2007) The spectrum of neuromyelitis optica. Lancet Neurol 6:805\u2013815","journal-title":"Lancet Neurol"},{"key":"3845_CR17","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/brain\/awm329","volume":"131","author":"Fisniku","year":"2008","unstructured":"Fisniku LK, Brex PA, Altmann DR et al (2008) Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis. Brain 131:808\u2013817","journal-title":"Brain"},{"key":"3845_CR18","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1001\/archneur.65.6.727","volume":"65","author":"Optic","year":"2008","unstructured":"Optic Neuritis Study G (2008) Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up. Arch Neurol 65:727\u2013732","journal-title":"Arch Neurol"},{"key":"3845_CR19","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1177\/1352458510386999","volume":"17","author":"Ruet","year":"2011","unstructured":"Ruet A, Deloire MS, Ouallet JC et al (2011) Predictive factors for multiple sclerosis in patients with clinically isolated spinal cord syndrome. Mult Scler 17:312\u2013318","journal-title":"Mult Scler"},{"key":"3845_CR20","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1212\/01.wnl.0000237354.10144.ec","volume":"67","author":"Tintore","year":"2006","unstructured":"Tintore M, Rovira A, Rio J et al (2006) Baseline MRI predicts future attacks and disability in clinically isolated syndromes. Neurology 67:968\u2013972","journal-title":"Neurology"},{"key":"3845_CR21","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1212\/WNL.0b013e318220abd4","volume":"77","author":"Calabrese","year":"2011","unstructured":"Calabrese M, Rinaldi F, Mattisi I et al (2011) The predictive value of gray matter atrophy in clinically isolated syndromes. Neurology 77:257\u2013263","journal-title":"Neurology"},{"key":"3845_CR22","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1136\/jnnp.2010.239715","volume":"82","author":"Jenkins","year":"2011","unstructured":"Jenkins TM, Ciccarelli O, Atzori M et al (2011) Early pericalcarine atrophy in acute optic neuritis is associated with conversion to multiple sclerosis. J Neurol Neurosurg Psychiatry 82:1017\u20131021","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3845_CR23","doi-asserted-by":"crossref","first-page":"e7638","DOI":"10.1371\/journal.pone.0007638","volume":"4","author":"Brettschneider","year":"2009","unstructured":"Brettschneider J, Tumani H, Kiechle U et al (2009) IgG antibodies against measles, rubella, and varicella zoster virus predict conversion to multiple sclerosis in clinically isolated syndrome. PLoS One 4:e7638","journal-title":"PLoS One"},{"key":"3845_CR24","doi-asserted-by":"crossref","first-page":"e11986","DOI":"10.1371\/journal.pone.0011986","volume":"5","author":"Brettschneider","year":"2010","unstructured":"Brettschneider J, Czerwoniak A, Senel M et al (2010) The chemokine CXCL13 is a prognostic marker in clinically isolated syndrome (CIS). PLoS One 5:e11986","journal-title":"PLoS One"},{"key":"3845_CR25","doi-asserted-by":"crossref","unstructured":"Orbach R, Gurevich M, Achiron A (2013) Interleukin-12p40 in the spinal fluid as a biomarker for clinically isolated syndrome. Mult Scler [Epub ahead of print]","DOI":"10.1177\/1352458513491166"},{"key":"3845_CR26","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1191\/135248506ms1263oa","volume":"12","author":"Brettschneider","year":"2006","unstructured":"Brettschneider J, Petzold A, Junker A et al (2006) Axonal damage markers in the cerebrospinal fluid of patients with clinically isolated syndrome improve predicting conversion to definite multiple sclerosis. Mult Scler 12:143\u2013148","journal-title":"Mult Scler"},{"key":"3845_CR27","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1177\/1352458510396922","volume":"17","author":"Villar","year":"2011","unstructured":"Villar LM, Espino M, Roldan E et al (2011) Increased peripheral blood CD5+ B cells predict earlier conversion to MS in high-risk clinically isolated syndromes. Mult Scler 17:690\u2013694","journal-title":"Mult Scler"},{"key":"3845_CR28","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJMoa1110740","volume":"367","author":"Srivastava","year":"2012","unstructured":"Srivastava R, Aslam M, Kalluri SR et al (2012) Potassium channel KIR4.1 as an immune target in multiple sclerosis. New Engl J Med 367:115\u2013123","journal-title":"New Engl J Med"},{"key":"3845_CR29","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1177\/1352458508093679","volume":"14","author":"Di","year":"2008","unstructured":"Di Pauli F, Reindl M, Ehling R et al (2008) Smoking is a risk factor for early conversion to clinically definite multiple sclerosis. Mult Scler 14:1026\u20131030","journal-title":"Mult Scler"},{"key":"3845_CR30","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/ana.21886","volume":"67","author":"Lunemann","year":"2010","unstructured":"Lunemann JD, Tintore M, Messmer B et al (2010) Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis. Ann Neurol 67:159\u2013169","journal-title":"Ann Neurol"},{"key":"3845_CR31","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1177\/1352458512472754","volume":"19","author":"Correale","year":"2013","unstructured":"Correale J (2013) If I had clinically isolated syndrome with magnetic resonance imaging diagnostic of multiple sclerosis, I would take vitamin D 10,000\u00a0IU daily: Yes. Mult Scler 19:137\u2013139","journal-title":"Mult Scler"},{"key":"3845_CR32","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1177\/1352458512474092","volume":"19","author":"Papeix","year":"2013","unstructured":"Papeix C, Lubetzki C (2013) If I had a clinically isolated syndrome with MRI diagnostic of MS, I would take vitamin D 10,000\u00a0IU daily: No. Mult Scler 19:140\u2013142","journal-title":"Mult Scler"},{"key":"3845_CR33","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0198-8859(93)90184-3","volume":"37","author":"Kelly","year":"1993","unstructured":"Kelly MA, Cavan DA, Penny MA et al (1993) The influence of HLA-DR and -DQ alleles on progression to multiple sclerosis following a clinically isolated syndrome. Hum Immunol 37:185\u2013191","journal-title":"Hum Immunol"},{"key":"3845_CR34","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1001\/archopht.1993.01090060061023","volume":"111","author":"Beck","year":"1993","unstructured":"Beck RW, Cleary PA (1993) Optic neuritis treatment trial. One-year follow-up results. Arch Ophthalmol 111:773\u2013775","journal-title":"Arch Ophthalmol"},{"key":"3845_CR35","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1474-4422(11)70262-9","volume":"11","author":"Comi","year":"2012","unstructured":"Comi G, De Stefano N, Freedman MS et al (2012) Comparison of two dosing frequencies of subcutaneous interferon beta-1a in patients with a first clinical demyelinating event suggestive of multiple sclerosis (REFLEX): a phase 3 randomised controlled trial. Lancet Neurol 11:33\u201341","journal-title":"Lancet Neurol"},{"key":"3845_CR36","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0140-6736(09)61259-9","volume":"374","author":"Comi","year":"2009","unstructured":"Comi G, Martinelli V, Rodegher M et al (2009) Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial. Lancet 374:1503\u20131511","journal-title":"Lancet"},{"key":"3845_CR37","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/S0140-6736(04)17271-1","volume":"364","author":"Filippi","year":"2004","unstructured":"Filippi M, Rovaris M, Inglese M et al (2004) Interferon beta-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomised, double-blind, placebo-controlled trial. Lancet 364:1489\u20131496","journal-title":"Lancet"},{"key":"3845_CR38","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1056\/NEJM200009283431301","volume":"343","author":"Jacobs","year":"2000","unstructured":"Jacobs LD, Beck RW, Simon JH et al (2000) Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group. New Engl J Med 343:898\u2013904","journal-title":"New Engl J Med"},{"key":"3845_CR39","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0140-6736(07)61194-5","volume":"370","author":"Kappos","year":"2007","unstructured":"Kappos L, Freedman MS, Polman CH et al (2007) Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study. Lancet 370:389\u2013397","journal-title":"Lancet"},{"key":"3845_CR40","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1177\/1352458512469695","volume":"19","author":"Comi","year":"2013","unstructured":"Comi G, Martinelli V, Rodegher M et al (2013) Effects of early treatment with glatiramer acetate in patients with clinically isolated syndrome. Mult Scler 19:1074\u20131083","journal-title":"Mult Scler"},{"key":"3845_CR41","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S1474-4422(09)70237-6","volume":"8","author":"Kappos","year":"2009","unstructured":"Kappos L, Freedman MS, Polman CH et al (2009) Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial. Lancet Neurol 8:987\u2013997","journal-title":"Lancet Neurol"},{"key":"3845_CR42","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1001\/archneurol.2011.1426","volume":"69","author":"Kinkel","year":"2012","unstructured":"Kinkel RP, Dontchev M, Kollman C et al (2012) Association between immediate initiation of intramuscular interferon beta-1a at the time of a clinically isolated syndrome and long-term outcomes: a 10-year follow-up of the Controlled High-Risk Avonex Multiple Sclerosis Prevention Study in Ongoing Neurological Surveillance. Arch Neurol 69:183\u2013190","journal-title":"Arch Neurol"},{"key":"3845_CR43","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1177\/1352458512442438","volume":"18","author":"Penner","year":"2012","unstructured":"Penner IK, Stemper B, Calabrese P et al (2012) Effects of interferon beta-1b on cognitive performance in patients with a first event suggestive of multiple sclerosis. Mult Scler 18:1466\u20131471","journal-title":"Mult Scler"},{"key":"3845_CR44","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1093\/brain\/120.11.2059","volume":"120","author":"Barkhof","year":"1997","unstructured":"Barkhof F, Filippi M, Miller DH et al (1997) Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 120(Pt 11):2059\u20132069","journal-title":"Brain"},{"key":"3845_CR45","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S1474-4422(07)70176-X","volume":"6","author":"Swanton","year":"2007","unstructured":"Swanton JK, Rovira A, Tintore M et al (2007) MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study. Lancet Neurol 6:677\u2013686","journal-title":"Lancet Neurol"},{"key":"3845_CR46","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1212\/01.wnl.0000335764.14513.1a","volume":"72","author":"Okuda","year":"2009","unstructured":"Okuda DT, Mowry EM, Beheshtian A et al (2009) Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome. Neurology 72:800\u2013805","journal-title":"Neurology"},{"key":"3845_CR47","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1177\/1352458512451943","volume":"19","author":"Granberg","year":"2013","unstructured":"Granberg T, Martola J, Kristoffersen-Wiberg M et al (2013) Radiologically isolated syndrome \u2013 incidental magnetic resonance imaging findings suggestive of multiple sclerosis, a systematic review. Mult Scler 19:271\u2013280","journal-title":"Mult Scler"},{"key":"3845_CR48","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1212\/WNL.0b013e31820d8b1d","volume":"76","author":"Okuda","year":"2011","unstructured":"Okuda DT, Mowry EM, Cree BA et al (2011) Asymptomatic spinal cord lesions predict disease progression in radiologically isolated syndrome. Neurology 76:686\u2013692","journal-title":"Neurology"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-013-3845-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00115-013-3845-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-013-3845-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T05:14:55Z","timestamp":1558588495000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00115-013-3845-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":48,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["3845"],"URL":"https:\/\/doi.org\/10.1007\/s00115-013-3845-1","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}